AVLN SCHEDULE 13G: SEC filing
Norwest Venture Partners XV, LP and affiliated entities
Filed with the SEC on · accession 0002149521-26-000002
AVLN filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 11, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.6% by the first close after the filing.
Summary of the filing
Norwest Venture Partners XV, LP and affiliated entities filed a Schedule 13G joint filing agreement regarding their passive ownership of Avalyn Pharma Inc. voting common stock.
Key details
How AVLN stock reacted
Close before
$34.56
Aug 10, 2026
First close after
+2.60%
$35.46
5 trading days
+10.68%
$38.25
Since filing
-15.65%
$29.15
✦ Ask GOAX AI about this filing — what it means for AVLN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVLN?
Click hereFrequently asked questions
What did AVLN file with the SEC on Aug 11, 2026?
AVLN filed a SCHEDULE 13G (SEC filing). Norwest Venture Partners XV, LP and affiliated entities filed a Schedule 13G joint filing agreement regarding their passive ownership of Avalyn Pharma Inc. voting common stock.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did AVLN stock react to this filing?
AVLN closed at $34.56 before the filing and $35.46 on Aug 11, 2026 (+2.60%). Five trading days later: $38.25 (+10.68%).
Other AVLN SEC filings
Get alerts when AVLN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days